Is therapeutic plasma exchange indicated for anticoagulant rodenticide (rat‑killer paste) poisoning?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Therapeutic Plasma Exchange is NOT Indicated for Anticoagulant Rodenticide Poisoning

Plasma exchange should not be used for anticoagulant rodenticide (rat-killer paste) poisoning. The standard and evidence-based treatment is immediate high-dose intravenous vitamin K1 combined with prothrombin complex concentrates (PCCs) for severe bleeding, not plasma exchange.

Recommended Treatment Algorithm

For Severe Bleeding with Rodenticide Poisoning:

  1. Immediate IV Vitamin K1: Administer 10 mg/kg intravenously 1, 2

    • Pretreat with 1 mg/kg prednisolone to prevent anaphylactic reactions 2
    • This is the cornerstone of therapy and rapidly increases coagulation factor activity
  2. Add PCCs for Life-Threatening Bleeding:

    • Dose: 25-50 IU/kg IV 1
    • Indicated when INR >1.5 (>1.2 for intracranial bleeding) 1
    • PCCs provide immediate reversal of vitamin K-dependent coagulation factors
    • Superior to fresh frozen plasma (FFP) with faster INR correction 1
  3. Monitor INR: Check within 30 minutes, then at 6-8 hours and 24 hours post-reversal 1

For Non-Severe Bleeding:

  • Vitamin K1 alone without PCCs 1
  • Symptomatic treatment and reassessment

Why NOT Plasma Exchange?

The evidence base is critically limited:

  • No guideline support: None of the major anticoagulation management guidelines 3, 1, 4, 5, 6, 5 recommend plasma exchange for rodenticide poisoning
  • Limited research evidence: Only one small pediatric study 7 showed potential benefit in rodenticide-induced hepatotoxicity (not coagulopathy), with 6 of 8 children surviving when plasma exchange was used as a bridge to liver transplantation
  • Wrong mechanism: Plasma exchange addresses hepatotoxicity complications, not the anticoagulant effect itself

Critical Distinction

Rodenticide poisoning causes two separate problems:

  1. Coagulopathy (anticoagulant effect): Treated with vitamin K1 ± PCCs
  2. Hepatotoxicity (yellow phosphorus rodenticides): May benefit from plasma exchange as bridge to transplant 7, 8

The question asks about anticoagulant rodenticide poisoning specifically—this is managed with vitamin K1 and PCCs, not plasma exchange.

Common Pitfalls to Avoid

  • Do NOT use FFP as first-line: PCCs are superior with faster INR correction and lower volume requirements 1, 4
  • Do NOT delay vitamin K1: Even if INR measurement is pending, start treatment immediately in severe bleeding 1
  • Do NOT confuse with hepatotoxic rodenticides: Yellow phosphorus poisoning may warrant plasma exchange for hepatotoxicity 7, 8, but this is a different clinical scenario

Prognosis

With appropriate vitamin K1 therapy, 94% of patients achieve physiological coagulation parameters within a median of 3 days 2. Only 10 of 52 dogs in one series required blood transfusions, and only one needed multiple transfusions 2.

Bottom line: Use IV vitamin K1 (10 mg/kg) as primary therapy. Add PCCs (25-50 IU/kg) for severe bleeding. Plasma exchange has no established role in managing the coagulopathy from anticoagulant rodenticides.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.